104 related articles for article (PubMed ID: 2009178)
1. Excretion of pseudouridine as an independent prognostic factor in renal cell carcinoma.
Rasmuson T; Björk GR; Hietala SO; Stenling R; Ljungberg B
Acta Oncol; 1991; 30(1):11-5. PubMed ID: 2009178
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of pseudouridine and prognosis of patients with malignant lymphoma.
Rasmuson T; Björk GR
Acta Oncol; 1995; 34(1):61-7. PubMed ID: 7865238
[TBL] [Abstract][Full Text] [Related]
3. Excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the upper urinary tract.
Kvist E; Sjølin KE; Iversen J
Scand J Urol Nephrol; 1990; 24(4):287-92. PubMed ID: 2274753
[TBL] [Abstract][Full Text] [Related]
4. Pseudouridine: a prognostic marker in non-Hodgkin's lymphomas.
Rasmuson T; Björk GR
Cancer Detect Prev; 1985; 8(1-2):287-90. PubMed ID: 4064048
[TBL] [Abstract][Full Text] [Related]
5. Pseudouridine: a modified nucleoside as biological marker in malignant lymphomas.
Rasmuson T; Björk GR
Cancer Detect Prev; 1983; 6(1-2):293-6. PubMed ID: 6883387
[TBL] [Abstract][Full Text] [Related]
6. Pseudouridine and beta-aminoisobutyric acid excretion in urine: diagnostic and prognostic value.
Kvist E; Sjølin KE
Scand J Urol Nephrol; 1990; 24(4):283-5. PubMed ID: 2274752
[TBL] [Abstract][Full Text] [Related]
7. Pseudouridine excretion in patients with psoriasis.
Clemmensen OJ; Kieffer M; Sjølin KE
Acta Derm Venereol; 1987; 67(4):310-4. PubMed ID: 2445149
[TBL] [Abstract][Full Text] [Related]
8. [Epidermal growth factor in the urine of patients with renal cell carcinoma and bladder tumor].
Ishikura K; Hasegawa M; Nomura K; Okamoto T; Tanji S; Abe T; Fujioka T; Ohhori T; Kubo T
Hinyokika Kiyo; 1991 Oct; 37(10):1229-34. PubMed ID: 1755416
[TBL] [Abstract][Full Text] [Related]
9. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract.
Koshida K; Harmenberg J; Stendahl U; Wahren B; Borgström E; Helström L; Andersson L
Urol Res; 1985; 13(5):213-8. PubMed ID: 4060364
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the advantage of determination of urinary pseudouridine for the early detection of a malignant transformation process].
Senden D; Buchet JP; Lauwerys R
J Toxicol Clin Exp; 1990; 10(7-8):473-80. PubMed ID: 2135063
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of pseudouridine in patients with hepatocellular carcinoma.
Tamura S; Amuro Y; Nakano T; Fujii J; Moriwaki Y; Yamamoto T; Hada T; Higashino K
Cancer; 1986 Apr; 57(8):1571-5. PubMed ID: 2418945
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical analysis for cancer of the esophagus using monoclonal antibodies specific for modified nucleosides.
Masuda M; Nishihira T; Itoh K; Mizugaki M; Ishida N; Mori S
Cancer; 1993 Dec; 72(12):3571-8. PubMed ID: 8252470
[TBL] [Abstract][Full Text] [Related]
13. Urinary pseudouridine excretion in myelomatosis.
Sørensen SH; Brown DA; Cooper EH; Kelly KA; MacLennan IC
Br J Cancer; 1985 Dec; 52(6):863-6. PubMed ID: 3907686
[TBL] [Abstract][Full Text] [Related]
14. Urinary pseudouridine and beta-aminoisobutyric acid in patients with low grade urothelial tumours. Relations between excretion and tumour recurrence.
Nyholm KK; Sjolin KE; Wolf H; Hammer M; Knudsen J; Stahl D; Nielsen HR
Biomedicine; 1976 May; 25(3):85-7. PubMed ID: 949520
[TBL] [Abstract][Full Text] [Related]
15. Creatinine at the evaluation of urinary 1-methyladenosine and pseudouridine excretion.
Honda I; Itoh K; Mizugaki M; Sasaki T
Tohoku J Exp Med; 1999 Jun; 188(2):133-8. PubMed ID: 10526874
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of renal cell carcinoma: a multivariate analysis].
Fujii Y; Owada F; Higashi Y; Okuno T; Noro A
Hinyokika Kiyo; 1996 Feb; 42(2):85-9. PubMed ID: 8712093
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of urinary glycosaminoglycan excretion in patients with renal cell carcinoma.
Sarica K; Türkölmez K; Soygür T; Ozer G; Yaman MO; Baltaci S; Bedük Y; Müftüoğlu YZ
Eur Urol; 1997; 31(1):54-7. PubMed ID: 9032535
[TBL] [Abstract][Full Text] [Related]
18. The urinary excretion of the nucleosides pseudouridine and 1-methylinosine during normal menstrual cycle.
Lehtiö H; Mäenpää PH
Clin Chim Acta; 1977 Oct; 80(1):181-5. PubMed ID: 908140
[TBL] [Abstract][Full Text] [Related]
19. Case report of renal cell carcinoma diagnosed in voided urine confirmed by CD10 immunocytochemistry.
Dubal SB; Pathuthara S; Ajit D; Menon S; Kane SV
Acta Cytol; 2011; 55(4):372-6. PubMed ID: 21791909
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis in the cases with renal cell carcinoma according to clinical parameters].
Fukuda M; Satomi Y; Asakura T; Hosaka M; Noguchi S; Kishida T; Kondou I; Ida T; Hirokawa M; Kumagai H; Shiozaki H; Ishizuka E; Miyai K; Fukuoka H; Sasaki K; Oogo Y; Koudaira T; Ogawa K; Nakahashi M; Matsuura K; Moriyama M; Udagawa K; Senga Y; Ishibashi Y; Shimura H
Nihon Hinyokika Gakkai Zasshi; 1998 Jul; 89(7):647-56. PubMed ID: 9739586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
